Saturday, October 16, 2010

Google Alert - health

News5 new results for health
 
Allergan's Botox Wins FDA Approval for Migraines
BusinessWeek
By Molly Peterson Oct. 15 (Bloomberg) -- Allergan Inc. won US regulatory approval to sell its wrinkle smoother Botox as a treatment for chronic migraine headaches after pleading guilty 10 days ago to charges it marketed the drug for unapproved uses. ...
See all stories on this topic »
It's About Time to Check the Fine Print on Your Health Plan
New York Times
By WALECIA KONRAD This year, even more than most, "doing nothing could cost you money," says Sara Taylor of Aon Hewitt, a benefits consultant. This is the time of year when your employer allows you to make changes to your benefits package — most ...
See all stories on this topic »
Hope for spinal cord patients
Los Angeles Times
The latest in how human embryonic stem cells are being put to use to treat spinal cord injuries and other debilitating conditions. Embryonic stem cells seen through a microscope. The use of therapeutic cells on a spinal cord injury is being tested on a ...
See all stories on this topic »

Los Angeles Times
Study Suggests Osteoporosis Drug Might Treat Loss of Bone in Jaw
BusinessWeek
By Amanda Gardner SATURDAY, Oct. 15 (HealthDay News) -- People suffering from a disfiguring loss of bone in the jaw may find help in the form of a long-used osteoporosis drug, two new studies suggest. Besides being linked to chronic, severe gum disease ...
See all stories on this topic »
Latest Findings Back Mammograms for Women in Their 40s
BusinessWeek
By Amanda Gardner FRIDAY, Oct. 15 (HealthDay News) -- Women in their 40s who are thoroughly confused by recent moves to push back the recommended age for having mammograms to 50 may find clarity in a new study that found having the screening scans in ...
See all stories on this topic »


Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.

Remove this alert.
Create another alert.
Manage your alerts.

No comments:

Post a Comment